Let's Talk Laterally

$450,000,000

Convertible Notes

Private Offering

Represented NASDAQ: APLD

Issuer

$1,590,000,000

7.00% Senior Secured Notes due 2031

Represented NASDAQ: APLD

Issuer

Underwritten Public Offering

Represented Special Situations Funds

Lead Investor

At-the-Market Offering

Represented H.C. Wainwright & Co.

Placement Agent

$460,500,000

Public Offering

Represented NASDAQ: CLDX

Issuer

$300,000,000

At-the-Market Offering

Represented NASDAQ: CLDX

Issuer

$345,000,000

Represented Celldex Therapeutics, Inc. (NASDAQ: CLDX), a clinical stage biotechnology company, in its underwritten public offering of $345 million of shares of its common stock

Private Placement Offering

Represented NASDAQ: CING

Issuer

$100,000,000​​

Private Placement

Represented Piper Sandler (NYSE:PIPR)

Issuer

$94,500,000

Underwritten Public Offering

Represented NASDAQ: CRBP

Issuer

$106,000,000

Represented Cyabra Strategy Ltd., now publicly listed on Nasdaq under the ticker symbol “CYAB”, in its definitive merger agreement with Trailblazer Merger Corporation I (Nasdaq: TBMC), a special purpose acquisition company (SPAC)

$169,000,000

Private Placement

Represented
Durable Capital Partners LP
Investor Counsel

$50,000,000

At-the-Market Offering

Represented NASDAQ: GANX

Issuer

$75,000,000

At-the-Market Offering​

Represented RBC Capital
Markets, LLC and BTIG, LLC ​
Sales Agents

$2,250,000,000

Private Placement

Represented Durable Capital Partners LP

Investor

At-the-Market Offering

Represented ROTH Capital Partners, LLC

Placement Agent

$373,800,000

Represented Jefferies, TD Cowen, Piper Sandler, and Citigroup as joint underwriters in Nektar Therapeutics (NASDAQ: NKTR) underwritten public offering of $373.8 million of shares of its common stock 

$150,000,000

At-the-Market Offering

Represented Guggenheim Securities, LLC and H.C. Wainwright & Co., LLC

Sales Agents

$800,000,000

De-SPAC

Represented Cohen & Company Capital Markets

Placement Agent

$200,000,000

Resented RMG ML Sports Holdings, a newly organized special purpose acquisition company (SPAC) formed as a Cayman Islands exempted company, in its $200 million Initial Public Offering (IPO)

Convertible Notes

Registered Direct Offering

Represented H.C. Wainwright & Co.

Placement Agent

$100,000,000

Private Placement

Represented Piper Sandler
(NYSE: PIPR)

Issuer

$460,500,000

Public Offering

Represented NASDAQ: CLDX

Issuer

$300,000,000

At-the-Market Offering

Represented NASDAQ: CLDX

Issuer

$345,000,000

Represented Celldex Therapeutics, Inc. (NASDAQ: CLDX), a clinical stage biotechnology company, in its underwritten public offering of $345 million of shares of its common stock

Represented Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) in its acquisition of Dr. Reddy's Laboratories’ license of E7777 from Eisai, Co., Ltd.

$150,000,000

At-the-Market Offering

Represented NASDAQ: CRBP

Issuer

$94,500,000

Underwritten Public Offering

Represented NASDAQ:CRBP

Issuer

$692,500,000

Represented Corbus Pharmaceuticals Holding Corp.(NASDAQ: CRBP) in its agreement to license CRB-701 from CSPC Megalith Biopharmaceutical Co., Ltd

$26,500,000

Private Placement

Represented NASDAQ: COYA

Issuer

Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal with Dr. Reddy’s Laboratories for its COYA 302 drug

$924,000,000

Represented Crown Laboratories
in its merger agreement with
evance Therapeutics, Inc.

(NASDAQ: RVNC)

$104,000,000

Represented
First Wave BioPharma, Inc.
(NASDAQ: FWBI) in its
acquisition of ImmunogenX

Represented
First Wave BioPharma, Inc.
(NASDAQ: FWBI) in its agreement
to license Capeserod from Sanofi
(NASDAQ: SNY)

$750,000,000

Represented Hildred Capital Management in raising capital for its continuation fund, extending its ownership of Crown Laboratories and Hyland’s Naturals

$66,809,220

Represented
Hildred Capital Management
in its acquisition of Hello Bello

$460,000,000

Public Offering 

Represented Jefferies LLC, TD Cowen, and Piper Sandler & Co.

Underwriters

Represented PicnicHealth in its acquisition of Allstripes

Represented Provention Bio, Inc. in an exclusive out-licensing of a novel potential treatment or cure for Hepatitis B Virus (HBV) to Enochian Biosciences, Inc.

$160,000,000

Private Placement

Represented NASDAQ: RLMD

Issuer

$100,000,000

Underwritten Registered Direct Offering

Represented NASDAQ: RLMD

Issuer

$80,000,000

Investment Financing

$888,000,000

Represented Sonnet BioTherapeutics, Inc. in a business combination transaction with Rorschach I LLC to launch Hyperliquid Strategies Inc.

$260,000,000

Represented Tolerance Bio in an exclusive license agreement with NeoImmuneTech for the development and commercialization of NT-17

$560,000,000

Represented Tolerance Bio in an exclusive license agreement with Tanabe Pharma Corporation for TLB-33 across all indications, covering worldwide development rights and commercialization rights outside Japan

Represented Tonix
Pharmaceuticals Holding Corp.
(NASDAQ: TNXP) in its licensing
of TNX-3600 and TNX-4100
from Columbia University

Represented Twill, Inc. in its
sale to DarioHealth Corp.
(NASDAQ: DRIO)

Counsel to Debtor

Counsel to Official Committee of Unsecured Creditors

Bankruptcy Counsel to
Defrauded Investors

Counsel to Official Committee of Unsecured Creditors

Counsel to Official Committee of
Unsecured Creditors

Counsel to Official Committee of Unsecured Creditors

Counsel to Official Committee of
Tort Claimant Creditors

Counsel to Official Committee of
Unsecured Creditors

Counsel to Official Committee of Unsecured Creditors

Counsel to Official Committee of
Unsecured Creditors

Counsel to Official Committee of
Unsecured Creditors

Counsel to Official Committee of
Unsecured Creditors

Counsel to Official Committee of Unsecured Creditors

Bankruptcy Counsel to
Defrauded Investors

Counsel to Equity Sponsor in Multi-Color Corporation Chapter 11

Counsel to Official Committee of
Unsecured Creditors

Counsel to Official Committee of Unsecured Creditors

Counsel to Official Committee of
Unsecured Creditors

Represent counsel on Behalf of 20,000+ Arbitration Claimants Who Allege Violations of Federal and State Privacy Laws in QVC Chapter 11

Counsel to Official Committee of Unsecured Creditors

Counsel to Official Committee of Unsecured Creditors

Counsel to Official Committee of Unsecured Creditors

Counsel to Official Committee of Unsecured Creditors

Counsel to Official Committee of Unsecured Creditors

Counsel to Official Committee of
Unsecured Creditors

Represents a COVID-19 test kit maker in lawsuits over federal National Strategic Stockpile contracts worth more than half a billion dollars

Defeated class certification for LexisNexis Risk Solutions in a proposed Fair Credit Reporting Act class action brought by 18,000+ NJ police officers and other public officials over Daniel's Law-related security freezes, with the court finding that most would-be class members suffered no injury and lacked standing

Representing funds managed by Pentwater Capital Management in securities litigation alleging that Boeing, following two aviation disasters, misled investors on the timeline of the plane’s return to service schedule, resulting in significant damages

Prevailed before the Delaware Supreme Court on behalf of Vistar Media, upholding the Court of Chancery's decision confirming the company's right to redeem investor notes for cash

Represented 8VC as the lead investor in the $35 million Series A funding round in Bobyard, the AI platform transforming how contractors perform construction takeoffs and estimates.

Represented Acrew Capital in a $42 million Series B financing in Arthur.AI, a platform for evaluating and improving generative AI and traditional machine learning models.

Represented Alpaca, a global leader in brokerage infrastructure whose APIs empower partners like Kraken, SBI Securities, and Dime!, in its $150 million Series D fund raise led by Drive Capital.

Represented Alpaca in its acquisition of WealthKernel, a wealthtech firm that specializes in digital investment infrastructure and tax-advantaged products.

Represented Anchorage Digital in its acquisition of Routable, a payouts platform that helps commercial and enterprise businesses onboard payees, automate compliance, and orchestrate high-volume payouts globally via a developer-first API.

Represented Arvo, the AI meeting assistant for financial institutions, in its acquisition by financial AI operating system Rogo.

Represented BEAMRaiL, an AI-based platform intended to reduce the amount of time police officers spend on administrative work, in its $700,000 pre-seed funding round from investors Shaper Capital and Flex Capital.

Represented Bessemer Venture Partners in a $150 million Series D financing of Farther Finance, Inc. a leading technology-centric financial advisory firm.

Represented Blockworks, the leading crypto data platform in its acquisition of Messari, a crypto data and market intelligence company.

Represented BoldVoice, the AI-powered voice coaching platform for non-native English speakers, in its $21 million Series A round led by Matrix.

Represented Coral Care, a platform expanding access to in-home pediatric speech, occupational, and physical therapy in its $13 million Series A round lead by Haymaker Ventures.

Represented Costanoa Ventures as an investor in the $100 million Series C round in Cape, America’s leading privacy-first mobile carrier.

Represented Dayforward Inc., a digitally native insurance technology company, in its acquisition by Fortitude Re through a newly formed entity renamed “Fortitude Life,” which will operate as a subsidiary of Fortitude Re under Dayforward.

Represented Durable Capital in the $43 million financing round in VieCure, a leading provider of intelligent software platforms for oncology care.

Represented Hurray’s GIRL BEER, a humor-led flavored light beer brand leading a new wave of beer built for the next generation of drinkers, in its $5 million funding round led by Lakehouse Ventures.

Represented FINTOP Capital as lead investor in a $5 million seed round for AI-native financial planning and analysis platform Cashboard.

Represented FINTOP Capital as lead investor in $18.5 million Series A funding round for Gridline, a turnkey alternatives management platform designed to help advisory firms build and manage private market investments.

Represented Fractional AI, a leading applied AI services company based in San Francisco in its acquisition by the recently announced AI-native enterprise services firm led by Anthropic, Blackstone, Hellman & Friedman and others.

Represented Healia, an AI-powered health benefits company, has raised a $14 million Series A led by 111° West Capital.

Represented Instaleap, a venture capital backed global enablement and fulfillment solutions services platform that empowers retailers to streamline and scale their online operations, in its acquisition by Instacart.

Represented IVP as the lead investor in the $75 million Series C funding round in Lumafield, a pioneering developer of industrial X-ray CT technology.

Represented Kalipso, a Barcelona, Spain-based provider, in its $3.2 million seed venture capital investment.

Represented Northzone as lead investor in a $200 million funding round for Blitzy, an autonomous software development platform, bringing the company’s valuation to $1.4 billion.

Represented Notable Capital as lead investor in a $40 million Series B financing round for Browserbase, a browser infrastructure platform for agentic software.

Represented PeakSpan Capital as lead investor in a $60 million Series B financing for Aligned, the AI deal workspace where sellers, buyers, and their AI agents run deals together.

Represented Pomelo Care, the national leader in evidence-based healthcare for women and children, in its $92 million Series C funding round led by Stripes.

Represented Portkey in its acquisition by global cybersecurity leader Palo Alto Networks (NASDAQ: PANW), establishing the AI Gateway as a mission-critical control plane for the enterprise, and enabling organizations to accelerate AI innovation with confidence.

Represented PraxisPro, a data intelligence and sales coaching platform for the life sciences industry, in its $6 million seed round led by AlleyCorp.

Represented Protege, an AI data platform unlocking access to trusted, real-world data at scale, in its $30 million Series A-1 funding round led by a16z.

Represented Reach Capital as an investor in the $11.6 million Series Seed round in Clair Health, a wellness wearable start-up designed to monitor hormones.

Represented Recess, the category pioneer and leader of the relaxation beverage space, in the closing of its Series B funding round of $30 million led by CAVU Consumer Partners.

Represented Scout AI, a frontier AI lab for U.S. defense in an oversubscribed $100 million Series A financing.

$135,000,000

Series A

*Led by Sequoia, FTX Ventures & 
Andreessen Horowitz

$3,500,000

Series Seed

$8,000,000

Series Seed

*Led by 6th Man Ventures

Represented Rainshine Global, Inc. in its strategic investment by Animoca Brands Japan, a subsidiary of Animoca Brands Corporation Limited.

Represented Floor NFTs in its
acquisition of WGMI.io

$8,000,000

Series A

*Led by Dragonfly Ventures III, L.P.

$7,000,000

Series Seed

$7,000,000

Series Seed

$35,000,000

Series C

$100,000,000

Series C

Represented Baxus
in its acquisition of BoozApp

$16,300,000

Series A

$130,000,000

Series B

$8,750,000

Investment

Represented Solmate Infrastructure (NASDAQ: SLMT) in a proposed business combination with RockawayX that would mark the transformation of the company from a passive digital asset treasury to an integrated infrastructure, liquidity, and asset management business.